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Mammalian gene expression patterns change profoundly in response to low oxygen levels.
These changes in gene expression programs are strongly inﬂuenced by post-transcriptional
mechanismsmediated bymRNA-binding factors: RNA-binding proteins (RBPs) andmicroR-
NAs (miRNAs). Here, we review the RBPs and miRNAs that modulate mRNA turnover
and translation in response to hypoxic challenge. RBPs such as HuR (human antigen
R), PTB (polypyrimidine tract-binding protein), heterogeneous nuclear ribonucleoproteins
(hnRNPs), tristetraprolin, nucleolin, iron-response element-binding proteins (IRPs), and
cytoplasmic polyadenylation-element-binding proteins (CPEBs), selectively bind to numer-
ous hypoxia-regulated transcripts and play a major role in establishing hypoxic gene
expression patterns. MiRNAs including miR-210, miR-373, and miR-21 associate with
hypoxia-regulated transcripts and further modulate the levels of the encoded proteins
to implement the hypoxic gene expression proﬁle. We discuss the potent regulation of
hypoxic gene expression by RBPs and miRNAs and their integrated actions in the cellular
hypoxic response.
Keywords: hypoxia, post-transcriptional gene regulation, microRNAs, RNA-binding proteins, mRNA turnover,
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INTRODUCTION
In response to hypoxic challenge, mammalian cells mount a
well-orchestrated response that includes speciﬁc changes in the
collective of expressed proteins. The altered gene expression pro-
gram allows the cell to respond to hypoxic conditions, triggering
adaptive processes that include changes in cell division, survival,
motility, or differentiation.
Changes in transcription directly affect the abundance of some
hypoxia-regulated proteins. The central mediator of hypoxic tran-
scriptional gene control is the hypoxia-inducible factor (HIF;
Rankin and Giaccia, 2008). HIF is a heterodimer transcription
factor composed of a hypoxia-inducible α subunit and a consti-
tutively expressed β subunit, each consisting of three isoforms
(Bracken et al., 2003; Semenza, 2008). Among the HIF α isoforms,
HIF-1α, and HIF-2α regulate similar sets of target genes, but only
HIF-1α is expressed constitutively (Semenza, 2003; Schoﬁeld and
Ratcliffe, 2004). In low oxygen (typically <2% O2), HIF-1 tran-
scriptionally activates many genes encoding proteins implicated in
angiogenesis, glucose metabolism, and cell proliferation and sur-
vival;many of these genes have hypoxia-response elements (HREs)
in their regulatory regions (Wenger et al., 2005). HIF-1 can also
regulate gene transcription in anHRE-independentmanner, via its
interaction histone acetyltransferases p300, CBP, and SRC-1 (Car-
rero et al., 2000). Other transcription factors that participate in
the transcriptional response to hypoxia include the nuclear factor
(NF)-κB complex, the activator protein 1 (AP1) complex, and
the activating transcription factor ATF-4 (reviewed in Shih and
Claffey, 1998; Gardner and Corn, 2008).
On a global scale, hypoxia markedly decreases total de novo
transcription and total RNA levels, accompanied by changes in his-
tone acetylation and methylation consistent with the notion that
chromatin modiﬁcations helps to suppress overall gene transcrip-
tion (Johnson and Barton, 2007; Johnson et al., 2008). Hypoxia
also triggers the ubiquitination and other post-translational mod-
iﬁcations of RNA polymerase II which alter its activity (Ignacak
et al., 2009).
Since transcription is overall reduced with hypoxia, as it occurs
in response to many damaging stimuli, the post-transcriptional
regulation of pre-existing mRNAs is particularly important. The
main post-transcriptional mechanisms affecting the levels of
expressed proteins during hypoxia are mRNA turnover and trans-
lational control. These processes are modulated efﬁciently by both
RNA-binding proteins (RBPs) and an emerging group of non-
coding RNAs (ncRNAs) among which the best-known members
are microRNAs. MicroRNAs are ∼22-nt long ncRNAs which
associate with cellular mRNAs and typically repress gene expres-
sion by reducing their half-life and/or inhibiting their transla-
tion (Fabian et al., 2010). In this review, we will focus on the
regulation of hypoxic gene expression by RBPs (Table 1) and
miRNAs (Table 2).
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Table 1 | RNA-binding proteins implicated in the hypoxic response.
RBP Target mRNA, binding site Conditions for association Influence on mRNA References
HuR HIF-1α (5′UTR) CoCl2 Translation (↑) Galbán et al. (2008)
HIF-1α (3′UTR) Hypoxia Stability (↑) Sheﬂin et al. (2004)
VEGF (3′UTR) Hypoxia Stability (↑) Levy et al. (1998)
PTB HIF-α (5′UTR) Hypoxia Translation (↑) Galbán et al. (2008)
HIF-1α (3′UTR) CoCl2 Translation (↑) Schepens et al. (2005)
VEGF (3′UTR) Hypoxia Stability (↑) Coles et al. (2004)
Insulin (3′UTR) Hypoxia Stability (↑) Tillmar et al. (2002)
TTP HIF-1α (3′UTR) Normoxia, Hypoxia Stability (↓) Kim et al. (2010)
MKP-3 (3′UTR) Hypoxia Stability (↑) Bermudez et al. (2011)
TIS11B VEGF (3′UTR) Normoxia Stability (↓) Ciais et al. (2004)
IRPs HIF-2α (5′UTR) Normoxia Translation (↓) Sanchez et al. (2007); Zimmer et al. (2008)
Nucleolin MMP-9 (3′UTR) Iron chelator, hypoxia Translation (↑) Fähling et al. (2005)
C-P4H-α (I) (5′UTR) Hypoxia Translation (↑) Fähling et al. (2006)
C-P4H-α (I) (3′UTR) Hypoxia Translation (↑) Fähling et al. (2006)
p53 (5′UTR) Stress Translation (↑) Takagi et al. (2005)
CPEBs HIF-1α (3′UTR) Hypoxia+ insulin Translation (↑) Hägele et al. (2009)
TIAR, TIA-1 HIF-1α (3′UTR) Hypoxia Translation (↓) Jin et al. (2000)
hnRNP A18 TXN (3′UTR) Hypoxia Translation (↑) Yang et al. (2006)
hnRNP A2 GLUT1 (3′UTR) Normoxia Translation (↓)? Hamilton et al. (1999)
Stability (↓)? Hamilton et al. (1999)
hnRNP L GLUT1 (3′UTR) Normoxia Translation (↓)? Hamilton et al. (1999)
Stability (↓)? Hamilton et al. (1999)
VEGF (3′UTR) Hypoxia Stability (↑) Jafarifar et al. (2011)
ERBP EPO (3′UTR) Hypoxia Stability (↑) Rondon et al. (1995); McGary et al. (1997)
RBM3, CIRP RPA2 (3′UTR) Cold stress, hypoxia? Translation (↑)? Lleonart (2010)
TRX (3′UTR) Cold stress, hypoxia? Translation (↑)? Lleonart (2010)
COX2 (3′UTR) Cold stress, hypoxia? Translation (↑)? Lleonart (2010)
GAPDH CCN2 Hypoxia Translation (↑) Kondo et al. (2011)
The table includes RBPs (column 1), the target mRNAs and region(s) with which they interact (column 2), the conditions that modulate their association with mRNAs
(column 3), and the post-transcriptional consequences of these interactions (column 4).
GENERAL POST-TRANSCRIPTIONAL GENE REGULATION
DURING HYPOXIA
CONTROL OF mRNA TURNOVER
Different stimuli can trigger wide changes in the rates of mRNA
turnover in the cell. Rapid increases or decreases inmRNA stability
can alter dramatically the levels of mRNA present in the cell, often
in the absence of transcriptional changes (Mitchell and Tollervey,
2001;Wilusz et al., 2001). In response to hypoxia, several RBPs and
miRNAs have been found to affect the half-lives of many speciﬁc
mRNAs, as reviewed in detail below.
Accelerated mRNA decay is observed when the relative half-life
of an mRNA is reduced in response to a given stimulus. Although
the mechanisms of mRNA degradation are not fully understood,
they involve enzymatic structures such as the exosome, processing
(P)-bodies, and the RNA-induced silencing complex (RISC). The
exosome is a large multi-protein complex that carries out 3′ → 5′
degradation of labile mRNAs following the recruitment by decay-
promoting RBPs such as AUF1 [also named hnRNP D (hetero-
geneous nuclear ribonucleoprotein)], TTP (tristetraprolin), BRF1
(butyrate response factor-1), and KSRP (KH domain-containing
RBP;Chen et al., 2001a;Butler,2002;Mukherjee et al., 2002;Gherzi
et al., 2004). P-bodies (PBs) are cytoplasmic structures that contain
proteins involved in mRNA decapping and 5′ → 3′ degradation
(Cougot et al., 2004; Kedersha et al., 2005; Parker and Sheth, 2007).
RISC-loaded miRNAs target speciﬁc mRNAs through sequence
similarity; the endoribonucleolytic activity of Argonaute 2 and
other enzymes initiates the degradation of target mRNAs (Fabian
et al., 2010). RBPs and miRNAs can recruit mRNAs to these
degradation machineries (reviewed by Butler, 2002; Kedersha and
Anderson, 2007; Fabian et al., 2010), but their speciﬁc involvement
in the hypoxia-triggered changes in mRNA turnover in mam-
malian systems awaits further study. MicroRNAs and several RBPs
such as TTP can modulate mRNA stability in response to hypoxia.
Increased mRNA stability, the converse process, consists in
the accumulation of an mRNA through the reduction of its
rate of decay. A stabilizing RBP typically associates with an
mRNA and enhances its half-life by competing with, and hence
preventing the binding of, degradation-promoting RBPs and
possibly also degradation-promoting miRNAs (e.g., Zhao et al.,
2000, reviewed by Abdelmohsen et al., 2008a). RBPs that pro-
mote mRNA stabilization include Hu proteins [the ubiquitous
HuR (HuA) and the primarily neuronal HuB (Hel-N1), HuC,
and HuD], NF90, the α-complex protein 1 (αCP1, also known
as Poly(C)-binding protein or PCBP1), nucleolin, heterogenous
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Table 2 | MicroRNAs implicated in the hypoxic response.
MicroRNA Regulatory
factor
Regulation of
microRNA
levels
Target mRNA Proposed biological effect References
miR-210 HIF-1α Hypoxia ISCU Mitochondria impairment Favaro et al. (2010), Chan et al. (2009)
Hypoxia NDUFA4 Mitochondria impairment Puisségur et al. (2011)
Hypoxia SDHD Mitochondria impairment Puisségur et al. (2011)
Hypoxia COX10 Mitochondria impairment Chen et al. (2010)
Hypoxia,
angiogenesis
EFNA3 Cell migration Fasanaro et al. (2008)
Hypoxia RAD52 DNA repair Crosby et al. (2009a)
Ischemia CASP8AP2 Apoptosis Kim et al. (2009)
Deleted
miR-210
gene
E2F3 Cell proliferation Giannakakis et al. (2008)
Hypoxia MNT Cell proliferation Zhang et al. (2009)
Hypoxia GPD1L HIF-1α stabilization Kelly et al. (2011)
miR-373 HIF-1α (?) Ectopic E-cadherin Invasion, metastasis Place et al. (2008)
Ectopic RAD23B DNA damage, repair Crosby et al. (2009a)
Ectopic RAD52 DNA damage, repair Crosby et al. (2009a)
miR-21 AP-1 (?) Acute
myocardial
infarction,
hypoxia
PDCD4 Anti-apoptotic, proliferation Cheng et al. (2010)
Hypoxia SPRY2 Proliferation, migration Sarkar et al. (2010)
Hypoxia PPARα Proliferation, migration Sarkar et al. (2010)
miR-20b (?) (ectopic) HIF-1α Reduced HIF-1α Cascio et al. (2010)
miR-199a AKT Normoxia HIF-1α Increased HIF-1α Rane et al. (2009, 2010)
miR-424 PU.1 Hypoxia(ECs) CUL2 HIF-1α stabilization Ghosh et al. (2010)
The table lists microRNAs (column 1), the factors that inﬂuence expression of the microRNA (column 2), the conditions that upregulate the microRNAs (column 3),
the target mRNAs with which they interact (column 4), and the proposed biological effect of the microRNA–mRNA interactions (column 5).
ribonucleoprotein (hnRNP) C1/C2, PTB, CUG-binding protein
2(CUG-BP2), the poly(A)-binding protein-interacting protein
2 (PAIP2), and erythropoietin mRNA-binding protein (ERBP;
Kiledjian et al., 1995; Rondon et al., 1995; McGary et al., 1997;
Onesto et al., 2004; Shi et al., 2007; Abdelmohsen et al., 2008a;
Hinman and Lou, 2008; Sawicka et al., 2008). The hypoxia-
induced binding of RBPs HuR, polypyrimidine tract-binding pro-
tein (PTB), and ERBP to target mRNAs, and the hypoxia-triggered
dissociation of hnRNP A2 and hnRBP L from target mRNAs,
all have been implicated in mRNA stabilization, as discussed
below.
CONTROL OF TRANSLATION
The relative utilization of a given mRNA for translation can also
be regulated by increasing or decreasing the loading of ribosomes
onto the mRNA (the translation initiation step) or the rates of
polypeptide synthesis and dissociation from the ribosome (the
elongation and termination steps, respectively). Themetabolic con-
sequence of energy depletion in hypoxia is a fast and general
inhibition of protein synthesis. Early global inhibition of mRNA
translation is attributed to eIF2α (eukaryotic translation initiation
factor 2α) phosphorylation, while under sustained hypoxic condi-
tions the mammalian target of rapamycin (mTOR) has a pivotal
role for the control of global mRNA translation (Koritzinsky et al.,
2006). For an excellent review of the hypoxia-regulated pathways
that alter global translation, see Wouters et al. (2005).
Translational inhibition occurs when, despite a lack of change in
steady-state mRNA abundance, translation of an mRNA declines.
RBPs that lower the translation of speciﬁc target mRNAs include
the T-cell intracellular antigen-1 (TIA-1), the TIA-1-related pro-
tein (TIAR), NF90, HuR, CUG-BP1, hnRNP A2, hnRNP L, and
the iron-response proteins (IRP1, IRP2; Hamilton et al., 1999;
López de Silanes et al., 2005; Kim et al., 2007; Leipuviene and
Theil, 2007; Abdelmohsen et al., 2008a). Many mammalian miR-
NAs studied to date also repress translation, whether or not they
also affect mRNA stability (Fabian et al., 2010). RBPs and miRNAs
can block translation by mobilizing mRNAs to subcytoplasmic
domains where translation is inhibited; such sites include PBs,
neuronal RNA granules, and stress granules (SGs), cytoplasmic foci
that form transiently in response to cell damage including hypoxia
(Gottschald et al., 2010) and harbor mRNAs that are typically sta-
ble and not translated. In general, these RNA granules contain
RBPs and miRNAs that can direct speciﬁc mRNAs to translation
and decay machineries (Anderson and Kedersha, 2006; Kedersha
and Anderson, 2007). The action of hypoxia upon these RBPs and
miRNAs is described below.
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Translational activation occurs when an mRNA is more efﬁ-
ciently translated in the absence of changes in mRNA abundance.
For instance, internal ribosome entry sites (IRES) have been pro-
posed to promote mRNA translation during hypoxia. IRESs are
cis-acting elements present in some5′untranslated regions (UTRs)
that mediate binding of ribosomes directly in front of the AUG
start codon, independent of the 5′ cap recognition (Le Quesne
et al., 2010); although IRESs are often highly structured, some-
times they lack secondary structure (Baird et al., 2007; Gilbert
et al., 2007; Xia and Holcik, 2009). RBPs acting as IRES trans-
acting factors (ITAFs) have also beenproposed to play a role during
hypoxia by supporting translational initiation. However, the func-
tional relevance of IRESs during hypoxia is the subject of ongoing
debate and alternative regulatorymechanisms have been discussed
(Fähling, 2009a).
RBPs that promote translation include HuR, PTB, the cyto-
plasmic polyadenylation-element-binding protein (CPEB), nucle-
olin, and hnRNP A18 (Yang et al., 2006; Abdelmohsen et al.,
2008a; Sawicka et al., 2008; Hägele et al., 2009); in speciﬁc
instances,miRNAs can also promote translation (Vasudevan et al.,
2007), but this does not appear to occur in response to hypoxia.
RBPs can promote translation by competing with (or other-
wise preventing the action of) RBPs or miRNAs that repress
translation. Hypoxic conditions increase the levels or activity of
numerous RBPs (e.g., HuR, PTB, nucleolin, hnRNP A18, CPEB),
thereby ensuring the selective upregulation of proteins neces-
sary for the hypoxic response, even though global translation
is potently repressed by the shutting off of the general trans-
lational machinery (Wouters et al., 2005). At the same time,
hypoxia can relieve the inhibitory action of some repressive
RBPs, such as IRPs, hnRNP A2, and hnRNP L, a process named
“post-transcriptional derepression,” and thus enhance translation of
speciﬁc mRNAs.
RNA-BINDING PROTEINS IMPLICATED IN THE HYPOXIC
RESPONSE
HuR
The product of the gene ELAVL1 (embryonic lethal, abnormal
vision, Drosophila-like 1), HuR is a 36-kDa RBP with three RNA-
recognition motifs (RRMs), through which it binds to numerous
mRNAs bearingU- orAU-rich sequences, typically present in their
3′-UTRs (López de Silanes et al., 2004; Hinman and Lou, 2008).
Although HuR is predominantly nuclear, its inﬂuence on the post-
transcriptional fate of targetmRNAs is linked to its translocation to
the cytoplasm, a process that is modulated by numerous transport
factors (reviewed in Abdelmohsen et al., 2008a; Hinman and Lou,
2008). In the cytoplasm, HuR stabilizes many target mRNAs and
can modulate the translation of several target mRNAs, enhancing
the translation of many target mRNAs and repressing the transla-
tion of other target mRNAs (reviewed by Hinman and Lou, 2008;
Srikantan and Gorospe, 2011). Through its inﬂuence on the pat-
terns of expressed proteins, HuR can affect key cellular processes
such as proliferation, differentiation, carcinogenesis, senescence,
apoptosis, and the response to immune and environmental stresses
(Wang et al., 2000, 2001; Gorospe, 2003; López de Silanes et al.,
2003; Lal et al., 2005; Abdelmohsen et al., 2007a,b; Hinman and
Lou, 2008; Srikantan and Gorospe, 2011).
In low oxygen, HuR potently elevates the expression of two
major hypoxia-inducible proteins, vascular endothelial growth
factor (VEGF) and HIF-1α, and likely regulates the levels and/or
translation of other target mRNAs encoding hypoxia-inducible
proteins (below). How hypoxia upregulates HuR function is
unclear. Treatment with the hypoxia mimetic CoCl2 did not
increase HuR cytoplasmic presence (Galbán et al., 2008), even
though many other stress agents did trigger this elevation (Wang
et al., 2000). Instead, HuR actions on hypoxia-regulated targets
might be inﬂuenced by other post-translational modiﬁcations of
HuR, including phosphorylation by kinases Chk2, PKC, or p38,
which modulate HuR’s ability to bind target mRNAs (Abdel-
mohsen et al., 2007b; Doller et al., 2007, 2008; Lafarga et al., 2009);
hypoxia activates Chk2 and PKC (Sahai et al., 1997; Xu et al., 2004;
Gibson et al., 2005), but it remains to be studied if these kinases
modulate HuR activity during hypoxia.
HIF-1α mRNA
The association of HuR with the HIF-1α 5′UTR promoted HIF-
1α translation in human cervical carcinoma cells (Galbán et al.,
2008). In normoxia, HuR overexpression increased the levels of
HIF-1α mRNA in actively translating polysomes and the de novo
HIF-1α translation. In cells treated with CoCl2, HuR binding to
the HIF-1α 5′UTR increased dramatically and HuR was necessary
for the induction of HIF-1α by CoCl2 treatment. Although the
HIF-1α 5′UTR has an IRES that enhances the constitutive trans-
lation of HIF-1α, this IRES did not appear to enhance HIF-1α
translation after hypoxia (Galbán et al., 2008), nor did it seem to
be affected by the presence of HuR or PTB (below). HuR bind-
ing to HIF-1α 3′UTR elevated HIF-1α mRNA levels in response
to androgens (Sheﬂin et al., 2004). Although HIF-1α abundance
is strongly increased by translational upregulation, the stabiliza-
tion of HIF-1α protein is the best-understood mechanism to raise
HIF-1α levels. In normoxia,HIF-1α is highly labile (with a half-life
of <10min) through the hydroxylation of conserved prolyl and
asparagyl residues that are targeted for decay by the von Hippel–
Lindau protein (pVHL), the recognition factor of an E3 ubiquitin
ligase complex (Kim and Kaelin, 2004; Schoﬁeld and Ratcliffe,
2004). During hypoxia, these hydroxylases are quickly inhibited,
resulting in the rapid and robust stabilization of HIF-1α (Schoﬁeld
and Ratcliffe, 2004). Interestingly, pVHL levels are also regulated
by HuR,which binds to theVHL mRNA, stabilizes it, and increases
pVHL protein levels (Abdelmohsen et al., 2008b, 2009; Danilin
et al., 2009). As hypoxia increases pVHL levels (Turcotte et al.,
2004), it is plausible thatHuRcontributes to elevating pVHLunder
such conditions.
VEGF mRNA and other HuR target mRNAs
A key factor in neoangiogenesis, VEGF induces the proliferation
of vascular endothelial cells and critically enhances tumor growth
(Yancopoulos et al., 2000). The VEGF mRNA is highly unsta-
ble in normoxia, but its half-life increases rapidly in response to
cytokines and stress conditions such as hypoxia (Levy et al., 1998;
Pagès et al., 2000). In hypoxia, VEGF mRNA is transcriptionally
upregulated by HIF-1 and related factors (Ema et al., 1997), but
it is also potently upregulated at the post-transcriptional level, via
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the interaction of HuR with the VEGF 3′UTR that stabilizes the
VEGF mRNA (Levy et al., 1998).
Numerous other hypoxia-inducible proteins are also encoded
by HuR target mRNAs, although HuR’s role in their hypoxia-
triggered increase has not been reported as-yet. The abundance
of GLUT1 (glucose transporter 1, a protein critical for glucose
uptake) increases by hypoglycemia and hypoxia, thereby ensur-
ing the availability of intracellular glucose at times of low energy
levels (Ouiddir et al., 1999; Qi and Pekala, 1999). While HIF-1
increases the expression of GLUT1 transcriptionally (Chen et al.,
2001b), HuR binding to the GLUT1 mRNA enhances its trans-
lation (Gantt et al., 2006), although it is not yet known if HuR
promotes GLUT1 expression during hypoxia. Similarly, hypoxia
also increases the levels of HIF-2α, tissue growth factor (TGF)-
β, c-Myc, and p53; although HuR interacts with these mRNAs
(Mazan-Mamczarz et al., 2003; Abdelmohsen et al., 2008a; Srikan-
tan and Gorospe, 2011), its role in enhancing the levels of the
encoded proteins during hypoxia has not been investigated. Col-
lectively, these proteins inﬂuence processes such as cell survival,
cell proliferation, carcinogenesis, and differentiation.
Through its inﬂuence on target mRNAs, HuR could be envi-
sioned to control hypoxic gene expression patterns in two stages.
Immediately after hypoxia, HuR helps to elevate expression of
HIF-1α and HIF-2α, which in turn increase the transcription of
hypoxia-inducible genes (e.g.,VEGF, TGF-β, p53, c-myc,GLUT1).
During this time, HuR could further assist in upregulating these
genes by binding to the corresponding mRNAs and enhancing
their stability and/or translation. At later times, however, HuR
likely helps to “shut off” hypoxic gene expression by enhancing
the levels of pVHL, which targets HIF-1α for degradation, thereby
helping to restore the levels of hypoxia-inducible proteins to basal
conditions.
PTB
A 57-kDa protein also known as hnRNP I, PTB contains four
RRMs through which it binds pyrimidine-rich sequences, pref-
erentially those contained within longer pyrimidine tracts with
cytosines (Auweter et al., 2007). PTB can bind to distant sites
on the same RNA molecule and thereby it can introduce large
RNA loops; such conformational changes are believed to be criti-
cal for PTB to recruit ribosomes onto IRESs to initiate translation
and for modulating the interaction of factors required for splicing
(Sawicka et al., 2008). PTB can also affect polyadenylation, cap-
dependent translation, and mRNA stability (Sawicka et al., 2008).
In response to hypoxia, PTB promotes HIF-1α mRNA translation
and stabilizes the VEGF and insulin mRNAs, as described below.
HIF-1α mRNA
PTBwas shown to interactwith theHIF-1α 5′UTRpolypyrimidine
tract and promoted HIF-1α translation in human embryonic kid-
ney cells. Although PTB was proposed to function by promoting
the formationof an IRES that facilitatedHIF-1α translationduring
hypoxia (Schepens et al., 2005), the HIF-1α IRES did not mediate
thehypoxia-triggered increase inHIF-1α translation (Galbán et al.,
2008). In human cervical carcinoma cells, PTB also associated
with the endogenous HIF-1α mRNA, primarily at the HIF-1α
3′UTR, and this interaction strongly increased HIF-1α transla-
tion after hypoxia or CoCl2 treatment (Galbán et al., 2008). The
PTB-triggered increase in HIF-1α translation was strongly depen-
dent on the presence of HuR, as HuR silencing severely reduced
both the binding of PTB to HIF-1α mRNA after CoCl2 treat-
ment and the PTB-stimulated translation of HIF-1α. Conversely,
lowering PTB reduced both HuR binding to the HIF-1α 3′UTR
and HIF-1α translation. This evidence supports a model whereby
PTB and HuR, likely binding on multiple sites of the HIF-1α
mRNA, together promote HIF-1α translation (Sheﬂin et al., 2004;
Schepens et al., 2005; Galbán et al., 2008).
VEGF mRNA
PTB formed a complex with the cold shock domain (CSD) protein
and the PTB/CSD complex promoted the stability of numerous
mRNAs, including VEGF mRNA in both normoxa and hypoxia
(Coles et al., 2004). Since CSD also regulates VEGF transcrip-
tion, the PTB/CSD complex was proposed to regulate in tandem
the transcription and stabilization of target mRNAs (Coles et al.,
2004). In addition, the VEGF 5′UTR contains two IRES (IRES A
and IRESB)which contribute to enhancingVEGF translation after
hypoxia; PTB associated with IRES B, but this interaction did not
appear to impact upon VEGF translation (Huez et al., 1998).
Insulin mRNA
The insulin mRNA is highly abundant in pancreatic β cells, where
it constitutes ∼30% of the cellular mRNA (Tillmar et al., 2002).
The insulin mRNA is highly stable,with a half-life of >24 h in rest-
ing conditions and an even longer half-life in the presence of high
glucose levels (Welsh et al., 1985; Tillmar et al., 2002). The 3′UTR
of insulin II mRNA was critical for the β-cell-speciﬁc glucose-
regulated expression (Wicksteed et al., 2001). PTB mRNA levels
increased markedly in pancreatic β cells cultured in high glucose;
through binding to the rat insulin 3′UTR polypyrimidine-rich
sequence (ins-PRS), PTB was proposed to increase insulin mRNA
stability (Tillmar and Welsh, 2002; Tillmar et al., 2002). This
interaction was inhibited by rapamycin, suggesting that signaling
through mTOR (mammalian target of rapamycin) controlled this
process (Tillmar and Welsh, 2004). Hypoxia also elevated insulin
mRNA levels in a manner that was independent of rapamycin but
dependent on the increased binding of PTB to the rat ins-PRS
(Tillmar and Welsh, 2004; Fred and Welsh, 2005). Other effects of
PTB, such as its ability to promote polyadenylation (Sawicka et al.,
2008; Millevoi et al., 2009), may also contribute to the increased
stability of the insulin mRNA.
TRISTETRAPROLIN (TTP) AND TTP-LIKE PROTEINS
The tristetraprolin family consists of three proteins with charac-
teristic tandem zinc-ﬁnger domains, including TTP (also known
as zinc-ﬁnger protein 36, ZFP36), ZFP36L1 or TIS11B (tetrade-
canoylphorbol acetate-inducible sequence 11B), and ZFP36L2 or
TIS11D. TTP is inducible by different stimuli, including hypoxia,
is predominantly cytoplasmic, and promotes the decay of target
mRNAs in a variety of systems (Carballo et al., 1998; Kim et al.,
2010). TTP was found to interact with the HIF-1α 3′UTR and
promoted the degradation of HIF-1α mRNA (Kim et al., 2010).
The generally reduced levels of TTP in many cancers was fur-
ther proposed to contribute to the increased HIF-1α levels seen
in many cancers (Brennan et al., 2009; Kim et al., 2010). In
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macrophages, the joint presence of hypoxia and lipopolysaccha-
ride (LPS) led to decreased tumor necrosis factor (TNF)-αmRNA
stability and TNF-α production, as well as to the reduced half-life
and steady-state levels ofmRNAs encodingother proinﬂammatory
cytokines [macrophage inﬂammatory protein 2 (MIP2), inter-
leukin (IL)-6, and granulocyte macrophage colony-stimulating
factor (GM-CSF)]. This reduction was due, at least in part, to
the decreased activity of p38, a kinase that phosphorylates and
thereby inactivates TTP in hypoxic, LPS-treated cells (Werno et al.,
2010). Hypoxia also increased the levels of MKP-3 [the mitogen-
activated protein (MAP) kinase phosphatase-3], a dual-speciﬁcity
phosphatase for MAP kinases ERK1/2. As TTP associated with
the MKP-3 3′UTR and lowered the stability of an MKP-3 3′UTR
reporter transcript, MKP-3 upregulation was attributed to the
reduced decay-promoting inﬂuence of TTP upon MKP-3 mRNA
during hypoxia (Bermudez et al., 2011).
The TTP-related protein TIS11B was found to interact with the
3′UTR of the VEGF mRNA and lowered VEGF mRNA stability
(Ciais et al., 2004). Very recently, the levels of TIS11B were shown
to be controlled by pVHL. In normoxic renal cell carcinoma (RCC)
cells ectopically expressing pVHL, increased abundance of the
microRNA hsa-miR-29b was responsible for decreasing TIS11B
mRNA stability and TIS11B protein levels (Sinha et al., 2009).
Hypoxia also increased TIS11B expression in pVHL-expressing
RCC cells, although the speciﬁc mechanisms were not identiﬁed.
IRON-REGULATORY PROTEINS
Iron-regulatory proteins (IRPs) interact with iron-responsive ele-
ments (IREs), specialized stem-loop structures present on mRNAs
that are post-transcriptionally regulated in response to changes
in iron concentration (Leipuviene and Theil, 2007). IREs present
in the 3′UTR can alter mRNA stability, as shown for the trans-
ferrin receptor (TfR) and divalent metal transporter 1 (DMT1)
mRNAs, while 5′UTR IREs block translation in a cap- and IRES-
independent manner, as shown for ferritin (Ft) and mitochondrial
aconitase (m-Aco) mRNAs (Schneider and Leibold, 2003; Leipu-
viene and Theil, 2007). IREs were identiﬁed in the 5′UTRs of
HIF-2α and HIF-1α, and the association of IRP1 and IRP2 with
the HIF-2α IRE repressed HIF-2α translation (Sanchez et al., 2007;
Zimmer et al., 2008).Although exposure tohypoxia increasedHIF-
2α expression and function, in conditions of iron deﬁciency the
interaction of IRP2 with the HIF-2α IRE led to strong repression
of HIF-2α translation (Sanchez et al., 2007). Hypoxia increased
HIF-2α expression by a process of translational derepression,
elicited by relieving the interaction of IRP1 with IRE. Several drug
compounds were identiﬁed which strengthened IRP/IRE interac-
tions, thereby blocking the hypoxia-triggered increase in HIF-2α
translation and HIF-2α levels (Zimmer et al., 2008). Whether
IRP/IRE interactions through the HIF-1α 5′UTR (Leipuviene and
Theil, 2007; Zimmer et al., 2008) are similarly implicated in the
regulation of HIF-1α expression by hypoxia has not been reported.
NUCLEOLIN
The 100-kDaRBPnucleolin has fourRRMs throughwhich itmod-
ulates gene expression during cell proliferation,carcinogenesis,
and viral infection. Exposure of human ﬁbrosarcoma cells to
an iron chelator (2,2-dipyridyl), a treatment that recapitulates
some aspects of hypoxia, enhanced the translation of matrix
metalloprotease-9 (MMP-9) without altering MMP-9 mRNA lev-
els. This increase was attributed to nucleolin’s increased associa-
tion with MMP-9 3′UTR (Fähling et al., 2005). In the same cell
system, long-term hypoxia increased the association of a 64-kDa
nucleolin cleavage productwith the 5′UTRand 3′UTRof the colla-
gen prolyl 4-hydroxylase-alpha(I) (C-P4H) mRNA (Fähling et al.,
2006). Through these interactions, the 64-kDa nucleolin enhanced
translation of the C-P4H mRNA and elevated C-P4H abundance
during hypoxia. Under conditions of stress, nucleolin (together
with the ribosomal protein RPL26) associated with the 5′UTR of
the mRNA encoding the tumor suppressor p53 and promoted its
translation (Takagi et al., 2005), although it has not been shown if
hypoxia employs a similar mechanism of p53 upregulation.
CPEBs
The cytoplasmicpolyadenylation-element-bindingprotein (CPEB)1
and 2 affect translation by changing the length of the 3′ poly(A) tail
of target mRNAs. CPEB1 and CPEB2 associated with the HIF-1α
3′UTR and repressed HIF-1α translation in untreated neuroblas-
toma cells (Hägele et al., 2009). In response to insulin treatment,
however, both CPEBs enhanced the hypoxia increased HIF-1α lev-
els by elevating HIF-1α translation via its 3′UTR, as shown using a
heterologous reporter RNA. The increase in HIF-1α translation by
insulin was accompanied by an elongation of the HIF-1α mRNA
poly(A) tail (Hägele et al., 2009).
TIA-1 AND TIAR
The levels of the RBPT-cell intracellular antigen-1 (TIA-1)-related
protein (TIAR) were potently upregulated in a rat model of brain
ischemia, associated with deprivation of oxygen, glucose, and
serum (Jin et al., 2000); conversely, TIAR levels were reduced by
anti-apoptotic drugs in amodel of retinal ischemia (Osborne et al.,
1998). These studies did not identify speciﬁc TIAR target mRNAs
but they linked TIAR to the cell death caused by hypoxia and
nutrient deprivation. TIA-1 and TIAR can aggregate within stress
granules (SGs) under speciﬁc stress conditions, including hypoxia,
and moreover HIF-1α expression was blocked in cells displaying
TIAR/TIA-1 SGs (Gottschald et al., 2010). Under potent hypoxia,
TIAR and TIA-1 inhibited HIF-1α expression, an effect that was
linked to an AU-rich element in the HIF-1α 3′UTR that was the
target of translational repression by TIAR. Other RBPs implicated
in mRNA turnover and translation linked to SG metabolism (e.g.,
G3BP, HuR, CPEB, FMRP, FXR1, PMR1, TTP, BRF1, YB-1, ZBP,
reviewed by Anderson and Kedersha, 2008) may also be involved
in controlling gene expression in response to hypoxia.
hnRNPs
Several hnRNPs have been implicated in the post-transcriptional
regulation of gene expression during hypoxia. HnRNP A18 asso-
ciated with the thioredoxin (TRX) mRNA 3′UTR and enhanced
its translation (Yang et al., 2006); formation of this complex was
induced via phosphorylation of hnRNP A18 by the hypoxia-
activated kinase GSK3β (glycogen synthase kinase 3β). HnRNP
A18 was proposed to enhance translation by interacting with
eIF4G, a component of the basic translational machinery that
interacts with the 5′ end of the mRNA, helping to form a loop
between the 3′ and 5′ ends of the mRNA, and thereby translated
thioredoxin more efﬁciently (Yang et al., 2006). It is unknown
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at present whether other hnRNP A18 target mRNAs, many of
which encode stress-response proteins (Yang and Carrier, 2001),
are similarly induced by hnRNP A18 during hypoxia.
Both hnRNP A2 and hnRNP L associated with the AU-rich ele-
ments in the GLUT1 3′UTR in numerous cell types and repressed
GLUT1 mRNA stability and translation (Hamilton et al., 1999).
Hypoxia enhancedGLUT1 expression by selectively decreasing the
interaction of GLUT1 mRNA with hnRNP A2 and hnRNP L, thus
relieving the repressive inﬂuence of these hnRNPs (Hamilton et al.,
1999).
Recently, VEGF expression was found to be repressed by
microRNAs miR-297 and miR-299 acting through a 3′UTR CA-
rich element (CARE) in the VEGF mRNA. Hypoxia promoted the
export of hnRNP L to the cytoplasm, where it interacted with the
VEGF CARE, competing with miR-297/miR-299 and preventing
microRNA-mediated repression (Jafarifar et al., 2011).
ERBP
The levels of the erythropoietin (EPO) mRNA-binding protein
(ERBP) increased in response to hypoxia and its binding activity
was modulated by sulfhydryl groups (Rondon et al., 1995). ERBP
stabilized the EPOmRNA innormoxic cells, but had amore potent
stabilizing inﬂuence under low oxygen conditions (McGary et al.,
1997).
COLD-INDUCIBLE RBPs
Hypoxia increased the expression levels of two highly homolo-
gous cold stress proteins, RNA-binding motif protein 3 (RBM3),
and cold-inducible RNA-binding protein (CIRP; Wellmann et al.,
2004). These glycine-rich RBPs have been implicated in modu-
lating global protein translation and function as RNA chaperones
that facilitate translation upon the perception of cold stress (Fujita,
1999; Smart et al., 2007). RBM3 and CIRP also interacted with the
3′UTR of speciﬁc target mRNAs [e.g., those encoding the replica-
tion protein A (RPA2), TRX, and cyclooxygenase (COX)2] likely
promoting their translation, although this effect was not studied
in hypoxia (Lleonart, 2010).
GAPDH
The enzymeglyceraldehyde-3-phosphate dehydrogenase (GAPDH)
was shown to associate with AU-rich elements in lym-
phokine mRNAs (Nagy and Rigby, 1995). In conditions of
hypoxia, GAPDH was found to interact with the 3′UTR of
CCN2/connective tissue growth factor (CTGF) mRNA and pro-
moted expression of CCN2, an inducer of tumor angiogenesis, in
human chondrosarcoma-derived cells (Kondo et al., 2011).
Table 1 lists the collection of RBPs implicated in modulating
the stability and translation of hypoxia-response genes.
MicroRNAs IMPLICATED IN THE HYPOXIC RESPONSE
MicroRNAs provide an important, newly recognized layer of
complexity to the post-transcriptional regulation of mammalian
gene expression. They exert their actions via pairing of a
“seed” region to partially complementary sites generally within
the 3′UTR of the target mRNA. The outcome of this inter-
action is most frequently post-transcriptional repression via
mRNAdegradation or/anddecreased translational efﬁciency (Bar-
tel, 2009; Fabian et al., 2010). The relative contribution of
these two mechanisms varies for individual [microRNA-target
mRNA] pairs.
Consistent with their demonstrated involvement in most phys-
iological processes, microRNAs have been proposed to ﬁne-tune
the cell’s adaption to low oxygen tension. During the past 5 years,
multiple groups have reported speciﬁc alterations in microRNA
proﬁles upon hypoxic stress (Hua et al., 2006; Donker et al., 2007;
Kulshreshtha et al., 2007a; Camps et al., 2008; Crosby et al., 2009a).
Collectively, these studies have identiﬁed over 50 microRNAs that
were either upregulated or downregulated in low oxygen; how-
ever most of these seem to be cell type-speciﬁc. Kulshreshtha et al.
(2007a) identiﬁed the ﬁrst group of hypoxia-inducible microR-
NAs, which included miR-210, miR-93, miR-30b, miR-181b, miR-
181c, miR-192, miR-195, and miR-21. Many subsequent studies
conﬁrmed miR-210 as a microRNA widely implicated in the
hypoxic response, and yet others identiﬁed miR-373, miR-498,
mimR-181b, and miR-30b (Kulshreshtha et al., 2007b; Crosby
et al., 2009a,b; Fasanaro et al., 2010). However, some microRNA
expression patterns in response to hypoxia vary among systems.
For example, some members of the let-7 family were induced in
squamous cell carcinoma, but downregulated in nasopharyngeal
carcinoma cells (Hua et al., 2006). The limited consistency between
microRNAexpression proﬁles is likely due to a combination of fac-
tors, including differences in detection technology and thresholds,
cellular context, and depth and duration of hypoxia. Below we
discuss the involvement of several prominent hypoxia-regulated
microRNAs in post-transcriptional gene regulation under low
oxygen (Table 2).
miR-210
In recent years, a number of studies have identiﬁed miR-210 as a
prototypical “hypoxia microRNA” (Hua et al., 2006; Kulshreshtha
et al., 2007a; Camps et al., 2008; Fasanaro et al., 2008; Gian-
nakakis et al., 2008; Pulkkinen et al., 2008; Zhang et al., 2009).
miR-210 induction in hypoxia is widely accepted as a hallmark
HIF-mediated response. The recruitment of HIF-1α to the pro-
moter of the miR-210 gene has been extensively validated by
multiple approaches, including ChIP (chromatin immunoprecip-
itation), HIF-1α knockdown and HIF-1α overexpression experi-
ments (Kulshreshtha et al., 2007a; Camps et al., 2008; Crosby et al.,
2009a). Together with bioinformatic analyses of clinical samples
conﬁrming strong associations between the expression of miR-
210 and that of conventional HIF-1α targets (Camps et al., 2008),
the data collectively support the notion that HIF-1α promotes
miR-210 upregulation during hypoxia.
Searches for bona ﬁde miR-210 targets have been under-
taken using a variety of prediction programs [PicTar, TargetScan,
DianaLab, Microcosm], together with integrative mRNA and
microRNAs proﬁling approaches. Using a novel strategy based on
the immunoprecipitation of RISC, in combination with microar-
rays and proteomics, Fasanaro et al. (2009) identiﬁed a diverse
spectrum of potential miR-210 targets, including genes involved
in proliferation, apoptosis, DNA repair, chromatin remodeling,
angiogenesis, and metabolism.
A key feature of adaptation to low oxygen is the shift in energy
metabolism frommitochondrial oxidative phosphorylation to gly-
colysis, a shift that is classically governed byHIF activation. Several
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reports independently demonstrated that miR-210 contributes to
this metabolic response by reducing the levels of a key target
protein, the evolutionarily conserved Iron–Sulfur Cluster Scaffold
Homolog (ISCU; Chan et al., 2009; Fasanaro et al., 2009; Chen
et al., 2010; Favaro et al., 2010). ISCU facilitates the assembly of
Fe-S clusters that are incorporated into enzymes involved in energy
production, including mitochondrial complex 1 and aconitase
(Tong and Rouault, 2006). The miR-210-elicited downregulation
of ISCU in response to hypoxia leads to decreased mitochondr-
ial electron transport activity and increased reliance on glycolysis.
Additional studies onmiR-210 suggest that thismicroRNAorches-
trates an “assault” on mitochondria during hypoxia, repressing
aerobic respiration components such as NDUFA4 (NADH dehy-
drogenase ubiquinone 1 α subcomplex 4), SDHD (succinate dehy-
drogenase complex subunit D), and COX10 (Giannakakis et al.,
2008; Chen et al., 2010; Puisségur et al., 2011). Expanding on these
ﬁndings, two feed-forward loops between miR-210 and HIF-1α
have been proposed. In the ﬁrst, Puisségur et al. (2011) provided
evidence that repression of SDHD in hypoxia by miR-210 con-
tributes to the maintenance of HIF-1α activity in hypoxia. In the
second, Kelly et al. (2011) showed that hypoxia-induced miR-210
targets the GPD1L mRNA, which encodes glycerol-3-phosphate
dehydrogenase 1-like, a newly identiﬁed inhibitor of HIF-1α, in
turn stabilizing HIF-1α protein.
The network of miR-210 effects was recently expanded to
hypoxia-driven angiogenesis. Blockade of miR-210 in human
endothelial cells inhibited the formation of capillary-like struc-
tures; the underlying mechanism proposed was the miR-210-
mediated repression of ephrin A3 (EFNA3), a negative modulator
of VEGF-dependent endothelial cell migration and tubulogene-
sis (Fasanaro et al., 2008; Pulkkinen et al., 2008). The inﬂuence
of miR-210 was also expanded to include another feature of
hypoxic cells, defective DNA repair, particularly downregulation
of homology-dependent DNA repair (HDR) genes (Bindra et al.,
2004). Inhibition of HDR during hypoxia likely involves miR-210-
lowered levels of RAD52 (Crosby et al., 2009a; Fasanaro et al.,
2009), a protein that assists with the loading of RAD51 onto
DNA (Benson et al., 1998). However, it is unclear whether induc-
tion of miR-210 is sufﬁcient to promote DNA damage or genetic
instability in hypoxic conditions.
While a lack of miR-210 compromises cell survival in response
to severe hypoxia (Kulshreshtha et al., 2007b; Fasanaro et al., 2008;
Favaro et al., 2010), it is still unclear if this occurs primarily as a
result of direct targeting of apoptotic pathways. The only apop-
totic target gene identiﬁed to date is CASP8AP2, which is highly
similar to FLASH, a mouse apoptotic protein that interacts with
the death-effector domain of Caspase 8 to promote cell death.
In mesenchymal stem cells following ischemic preconditioning,
repression of this pathway by miR-210 appears to be critical for
the maintenance of cell viability (Kim et al., 2009). Whether the
protective role of miR-210 during hypoxia in cancer cells is mainly
the consequence of the metabolic shift described above, the reg-
ulation of CASP8AP2 expression, or the impact of miR-210 on
multiple pathways remains an open question.
Finally, miR-210 has also been proposed to act as regulator
of the cell division cycle, but this effect appears to be context-
dependent. In ovarian cancers, contrary to other solid tumors,
miR-210 is often underexpressed as a result of genomic dele-
tions, leading to increased expression of the transcription factor
E2F3,which in turn accelerates cell cycle progression (Giannakakis
et al., 2008). This paradigm seems to mirror the results with
xenografts overexpressing miR-210, which grow slower than con-
trol xenografts (Huang et al., 2009). Another cell cycle effect was
proposed by Zhang et al. (2009) who found that miR-210 over-
expression in cancer cell lines bypasses hypoxia-induced cell cycle
arrest by downregulating MNT, a c-MYC antagonist. The relative
contribution of these mechanisms to cell cycle alterations in the
hypoxic tumor is unknown at present.
miR-373
The induction of miR-373 by hypoxia has been reported in HeLa,
MCF-7, and squamous cell carcinoma cell lines (Hebert et al.,
2007; Crosby et al., 2009a). Similarly to miR-210, the increase in
miR-373 levels by hypoxia appears to be HIF-1α-dependent, with
at least one functional HRE identiﬁed in its promoter. Consis-
tently, HIF-1α knockdown by shRNA blocks miR-373 induction
in hypoxic cells (Crosby et al., 2009a).
Given that miR-373 expression has been correlated with
increased proliferation and tumorigenesis, a mechanistic under-
standing of its function and targets is highly relevant for cancer
biology (Voorhoeve et al., 2006). MiR-373 was found to directly
transactivate E-cadherin gene expression through pairing with
complementary promoter sequences. This potentially novelmech-
anismof actionmaybedirectly relevant to invasion andmetastasis,
two processes that are known to be promoted by tumor hypoxia
(Berx and Van Roy, 2001; Place et al., 2008). Recent work demon-
strated that forced expression of miR-373 leads to a reduction
in the RAD23B nucleotide excision repair protein, as well as in
RAD52 (Crosby et al., 2009a). As with miR-210, it is not currently
known whether induction of miR-373 is sufﬁcient to promote
genotoxic damage during hypoxia.
miR-21
Hypoxia-mediated induction of miR-21 has been reported in sev-
eral cancer cell lines, in pulmonary artery smooth muscle (PDAC),
and in human vein endothelial cells (HUVEC; Kulshreshtha et al.,
2007a; Pulkkinen et al., 2008; Sarkar et al., 2010). In contrast,miR-
21 levels decreased upon exposure of cardiac myocytes to hypoxia
and remained unchanged in breast cancer cells (Camps et al., 2008;
Sayed et al., 2010).
MiR-21 is arguably the most frequently upregulated onco-
microRNA (oncomir) in human tumors (Volinia et al., 2006;
Iorio et al., 2007; Lui et al., 2007; Tetzlaff et al., 2007; Tran
et al., 2007). MiR-21 is believed to play a pro-survival role in
deeply hypoxic/anoxic cancer microenvironment and in ischemic
disorders, such as acute myocardial infarction, where miR-21 pre-
vents hypoxia-induced cell apoptosis by suppressing expression
of the programmed cell death protein 4 (PDCD4). It may also
be required for cell viability during ischemia/reperfusion (Dong
et al., 2009; Cheng et al., 2010). MiR-21 may also inhibit pro-
liferation under hypoxia, as suggested by its inhibition of the
expression of Cdc25A, a key cell cycle progression protein (de
Oliveira et al., 2009). In human pulmonary artery smooth muscle
cells (PASMC), elevated miR-21 participates in hypoxia-triggered
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proliferation and cell migration by reducing the expression levels
of targets such as PDCD4, Sprouty 2 (SPRY2), and peroxisome
proliferator-activated receptor-α (PPARα; Sarkar et al., 2010).
A role for HIF in directly upregulating miR-21 seems unlikely,
and whether miR-21 can be regarded as a bona ﬁde hypoxia-
regulated transcript remains unclear. Among the factors that may
elevate miR-21 expression in tumors and/or hypoxic cells, the
leading candidate is AP-1, itself a hypoxia-response transcription
factor (Fujita et al., 2008; Nanduri et al., 2008).
HIF-1α-DIRECTED microRNAs
MicroRNAs miR-20b, miR-199a, and miR-424 are also relevant
to the hypoxic response by affecting HIF-1α expression. miR-20b
directly suppressed HIF-1α expression in MCF-7 breast cancer
cells (Cascio et al., 2010). In contrast, miR-199a is acutely down-
regulated in cardiacmyocytes in anAKT-dependentmanner under
low oxygen conditions; in turn, this downregulation allows a rapid
increase of its target, HIF-1α mRNA (Rane et al., 2009, 2010).
An indirect feed-back mechanism was identiﬁed for miR-424
in endothelial cells, where PU.1-upregulated miR-424 leads to a
reduction in the expression of Cullin 2 (CUL2), a critical compo-
nent of the ubiquitin ligase system that degrades HIF-1α (Ghosh
et al., 2010) and thereby elevates HIF-1α. Collectively, the recent
work on hypoxia-related microRNAs has added a new dimen-
sion to the complexity of the hypoxic response, with implications
in metabolism, cell cycle control, apoptosis, and angiogenesis.
The integration of several RBPs and microRNAs in the hypoxic
response elicited by HIF-1α is presented in Figure 1.
CONCLUSION AND PERSPECTIVES
The complexity of the regulation of gene expression in response to
low oxygen tension is striking. Many recent studies of gene regula-
tion in hypoxia have uncovered diverse feed-back loops of repres-
sion and activation at the transcriptional and post-transcriptional
levels. Transcriptional activation of hypoxia-inducible factors is
critical for long-term adaptation, and its integration with post-
transcriptional networks gives rise to a rich variety of modiﬁ-
cations that are essential for responses by tissues with speciﬁc
requirements.
The proteomic constellation of each cell is unique – it is
determined by its state of differentiation and tissue environment.
Cellular hypoxic adaptation and survival depends on the manner
the cell senses oxygen levels and its ability to respond to lower
ATP concentrations. The gene expression program and ensuing
FIGURE 1 | Schematic of RBPs and microRNAs influencing the
hypoxic response by HIF-1α. RBPs and microRNAs that interact with
HIF-1α mRNA and modulate the production of HIF-1α protein in hypoxia.
In the nucleus, HIF-1α transcriptionally upregulates the expression of
target genes bearing hypoxia-response elements (HREs) in their
promoters, including those that encode GLUT1 and VEGF mRNAs and
those that encode microRNAs like miR-210 and likely also miR-373.
In turn, miR-210 can modulate the production of HIF-1α by repressing
the production of GPD1L; other RBPs and other microRNAs assist in
modulating the expression of additional HIF-1α stability regulators
(e.g., VHL, CUL2), and other hypoxia-response proteins like GLUT1
and VEGF.
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metabolic changes activated by oxygen deprivation are inﬂuenced
by the assortment of pre-existing trans-acting factors, as well as
by second messenger cascades activated by extracellular stimuli.
Cells communicate by signaling molecules delivered to the cell
in paracrine or endocrine fashion. Depending on the types of
receptors expressed in the cell, different sets of signals can be
activated and interfere with hypoxia-inducible second messenger
cascades and transcriptional/post-transcriptional responses. The
close relationship between oxygen and iron metabolism (Chepelev
and Willmore, 2011) and the modulation of hypoxia responses
by insulin or lipopolysaccharides are only some examples of the
inﬂuence of stimuli upon the speciﬁc transcriptional and post-
transcriptional responses to hypoxia. The data gathered so far
suggest the existence of distinct cell type-speciﬁc usage of hypoxic
gene regulatory sites located in the DNA (e.g., promoter, enhancer,
silencer regions) and/or in themRNAUTRs. In addition,RBPs and
miRNAs could help to balance the expression pattern of hypoxia-
inducible genes. For instance, the most extensively investigated
hypoxia response, the HIF-activated gene expression system, is
primarily triggered by changes in oxygen concentration. How-
ever, HIF activity is modulated by several other pathways and
secondary cascades, including reactive oxygen species,AMPK, and
the phosphatidylinositol 3-kinase (PI3K)/Akt pathway (Fähling,
2009b). The inﬂuence of these signaling systems upon the RBPs
andmicroRNAs discussed in this review remains to be investigated
in depth.
In closing, it should be noted that although several trans-
binding factors have been identiﬁed that modulate the expression
of hypoxia-response genes in cultured cells, particularly in cancer
cells, their function under hypoxic conditions in tissues, organs,
and organisms remains largely unknown. It is well known that
tumors become hypoxic, that highly proliferating cells need more
energy (and hence oxygen), and that inhibition of tumor vascu-
larization is able to suppress tumor growth. However, compared
to differentiated cells, cancer cells elicit markedly distinct adap-
tive responses to hypoxia, including different changes in gene
expression, energy usage, proliferation, and apoptosis. In addition,
hypoxia is also important during the adaptation to stress condi-
tions and embryonic development (Dunwoodie, 2009). In light
of the fact that hypoxia may elicit different responses depending
on the species, sex, in vivo or in vitro conditions, oxygen ten-
sion, cellular origin and differentiation state, it is challenging to
describe a universal pattern of adaptive gene expression in the
hypoxic response. In summary, a great deal of knowledge has been
gathered about the trans-acting RBPs and miRNAs that control
hypoxic gene expression patterns. The stage is now ready to study
how their actions are integrated within the context of speciﬁc
hypoxic cell environments.
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